CG
APYX icon

Caprock Group’s Apyx Medical APYX Stock Holding History

Caprock Group’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,878
Closed -$39.6K – 1200
2025
Q3 		$39.6K Buy
+19,878
New +$42.1K ﹤0.01% 1115
2025
Q1 		$27.4K Hold
20,000
– – ﹤0.01% 1068
2024
Q4 		$31.6K Hold
20,000
– – ﹤0.01% 989
2024
Q3 		$24.8K Hold
20,000
– – ﹤0.01% 899
2024
Q2 		$26.8K Sell
20,000
-600
-3% -$885 ﹤0.01% 851
2024
Q1 		$28K Hold
20,600
– – ﹤0.01% 712
2023
Q4 		$54K Sell
20,600
-35
-0.2% -$85 ﹤0.01% 686
2023
Q3 		$66K Buy
20,635
+35
+0.2% +$163 0.01% 645
2023
Q2 		$104K Sell
20,600
-40,000
-66% -$203K 0.01% 642
2023
Q1 		$175K Buy
+60,600
New +$177K 0.01% 603

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Caprock Group's APYX Position: Q4 2025 in Review

Caprock Group sold out of Apyx Medical (APYX) in Q4 2025, closing a stake of 19,878 shares — an estimated $39.6K sold.

Caprock Group first reported a position in APYX in Q1 2023 and held it in 10 quarters. The position peaked at $175K in Q1 2023. 59 funds tracked by Wall St. Rank hold APYX as of Q4 2025.

  • Caprock Group reported no remaining Apyx Medical position as of Q4 2025 after selling out during the quarter.
  • Caprock Group sold 19,878 Apyx Medical shares in Q4 2025, an estimated $39.6K.
  • Caprock Group first reported a position in Apyx Medical in Q1 2023 and held it in 10 quarters.
  • Caprock Group's Apyx Medical position peaked at $175K in Q1 2023.
  • 59 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2025.

Based on Caprock Group's 13F filing for Q4 2025, filed 28 Jan 2026.